JP Morgan Chase’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Hold
33,000
﹤0.01% 4377
2025
Q4
$1.45M Buy
+33,000
New +$1.37M ﹤0.01% 4347
2025
Q3
Sell
-6,300
Closed -$278K 7495
2025
Q2
$278K Sell
6,300
-20,700
-77% -$827K ﹤0.01% 5070
2025
Q1
$997K Buy
+27,000
New +$962K ﹤0.01% 4347
2024
Q1
Sell
-1,500
Closed -$36K 7525
2023
Q4
$36K Sell
1,500
-3,100
-67% -$67.4K ﹤0.01% 6107
2023
Q3
$101K Buy
4,600
+1,900
+70% +$39.7K ﹤0.01% 5467
2023
Q2
$51.6K Buy
+2,700
New +$52K ﹤0.01% 5709
2023
Q1
Sell
-35,000
Closed -$561K 6847
2022
Q4
$561K Buy
+35,000
New +$571K ﹤0.01% 4436
2022
Q3
Sell
-56,000
Closed -$1.17M 6560
2022
Q2
$1.17M Buy
+56,000
New +$1.15M ﹤0.01% 3966

Other funds holding EXEL

JP Morgan Chase's EXEL Position: Q1 2026 in Review

JP Morgan Chase increased its Exelixis (EXEL) stake by 6.9% in Q1 2026, buying an estimated $2.24M and bringing the position to 810,849 shares worth $34M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

JP Morgan Chase first reported a position in EXEL in Q2 2013 and has held it in 45 quarters since. The position peaked at $273M in Q1 2022. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • JP Morgan Chase held 810,849 shares of Exelixis worth $34M as of Q1 2026.
  • JP Morgan Chase bought 52,089 Exelixis shares in Q1 2026, an estimated $2.24M.
  • Exelixis made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1645 holding.
  • JP Morgan Chase first reported a position in Exelixis in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Exelixis position peaked at $273M in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.